首页> Current cancer drug targets> Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma.

Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma.

导出原文传递

翻译打印收藏纠错

第一作者： Yingyi,Wang

第一单位： Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

作者： Yingyi,Wang ^[1] ; Bao,Jin ^[2] ; Na,Zhou ^[1] ; Zhao,Sun ^[1] ; Jiayi,Li ^[2] ; Qiao,Chen ^[2] ; Xiangan,Wu ^[2] ; Yi,Zhou ^[2] ; Yue,Shi ^[2] ; Xin,Lu ^[2] ; Xinting,Sang ^[2] ; Yilei,Mao ^[2] ; Shunda,Du ^[2] ; Wenze,Wang ^[3] ; Chunmei,Bai ^[1]

作者单位： Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China ^[1] Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China ^[2] Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China ^[3]

关键词 Extrahepatic cholangiocarcinoma WDFY3 neoantigens immune cell infiltration immune signature genes prognosis tumor mutation burden